If I Could Buy Only 1 Growth Stock, This Would Be It
There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their hard-earned money into specific companies based on their preferences, risk tolerance, goals, investment horizons, available capital, etc. Because these factors vary quite a bit from one person to the next, choosing a single stock everyone "should" invest in is hard.However, my preference lies in the healthcare sector, and my favorite growth stock is Vertex Pharmaceuticals (NASDAQ: VRTX). Read on to discover why many could benefit from investing in this terrific company.Economic fluctuations affect consumers, businesses, and, by extension, the performance of equities. During recessions, people are less likely to buy various goods and services, leading to lower revenue and profits for their sellers. Corporations that develop and market lifesaving drugs are somewhat insulated from this problem. Physicians won't stop prescribing medicines for cystic fibrosis (CF), a rare and life-threatening disease when left untreated, when the economy is in the dumps.Continue reading
There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their hard-earned money into specific companies based on their preferences, risk tolerance, goals, investment horizons, available capital, etc. Because these factors vary quite a bit from one person to the next, choosing a single stock everyone "should" invest in is hard.
However, my preference lies in the healthcare sector, and my favorite growth stock is Vertex Pharmaceuticals (NASDAQ: VRTX). Read on to discover why many could benefit from investing in this terrific company.
Economic fluctuations affect consumers, businesses, and, by extension, the performance of equities. During recessions, people are less likely to buy various goods and services, leading to lower revenue and profits for their sellers. Corporations that develop and market lifesaving drugs are somewhat insulated from this problem. Physicians won't stop prescribing medicines for cystic fibrosis (CF), a rare and life-threatening disease when left untreated, when the economy is in the dumps.
